Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - DX (Group) Plc

10 Oct 2023 15:22

Killik & Co. LLP - Form 8.3 - DX (Group) Plc

Killik & Co. LLP - Form 8.3 - DX (Group) Plc

PR Newswire

LONDON, United Kingdom, October 10

FORM 8.3

PUBLIC DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Killik & Co LLP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeDX (Group) plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure09/10/2023
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:GB00BJTCG679- ORD GBP
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:6,631,4431.10%
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:6,631,4431.10 %

Deceased person held 11,538 shares in the above line of stock as of 4th October

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
Ordinary GBPSale71,64942.24

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:10/10/2023
Contact name:Emily Bates
Telephone number*:02073370658

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.



Date   Source Headline
6th Feb 20194:40 pmRNSSecond Price Monitoring Extn
6th Feb 20194:35 pmRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSTrading Statement
17th Dec 20183:06 pmRNSDirector/PDMR Shareholding
4th Dec 201812:29 pmRNSResult of AGM
4th Dec 20187:00 amRNSAGM Statement
3rd Dec 20187:00 amRNSDirector Disclosure
7th Nov 201811:07 amRNSDirector Declaration
29th Oct 20184:35 pmRNSPrice Monitoring Extension
15th Oct 20187:00 amRNSNotice of AGM
2nd Oct 20183:47 pmRNSPreliminary Results - replacement
2nd Oct 20187:00 amRNSPreliminary Results
14th Aug 20184:40 pmRNSSecond Price Monitoring Extn
14th Aug 20184:35 pmRNSPrice Monitoring Extension
26th Jul 20187:00 amRNSGrant of share awards and PDMR notification
18th Jul 20187:00 amRNSTrading Update
14th Jun 20187:00 amRNSDirector/PDMR Shareholding
6th Jun 20183:02 pmRNSHolding(s) in Company
25th May 201810:50 amRNSGrant of Share Awards and PDMR Shareholding
24th May 20185:47 pmRNSHolding(s) in Company
23rd May 20188:45 amRNSCompletion of Transaction and Director Dealing
23rd May 20187:00 amRNSDirector/PDMR Shareholding
22nd May 20185:04 pmRNSTotal Voting Rights
22nd May 201811:38 amRNSResult of General Meeting
3rd May 20186:32 pmRNSFundraising and Loan Note Cancellation
29th Mar 20187:00 amRNSInterim Results
21st Mar 20187:00 amRNSAppointment of Chief Financial Officer
19th Mar 20187:00 amRNSNotice of Results
5th Feb 20183:29 pmRNSHolding(s) in Company
29th Jan 20187:00 amRNSChange of Adviser
3rd Jan 20185:15 pmRNSDirector/PDMR Shareholding
22nd Dec 20171:19 pmRNSCompletion of Loan Note issue
22nd Dec 20171:14 pmRNSDirector/PDMR Shareholding
22nd Dec 20171:13 pmRNSGrant of share awards and PDMR notification
18th Dec 201711:09 amRNSHolding(s) in Company
15th Dec 201711:41 amRNSResult of GM
8th Dec 201712:22 pmRNSResult of AGM
28th Nov 20177:00 amRNSRe: GM Notice, Circular and Incentive Awards
14th Nov 20179:00 amRNSPosting of Annual Report & Notice of AGM
27th Oct 201712:07 pmRNSSecond Price Monitoring Extn
27th Oct 201712:02 pmRNSPrice Monitoring Extension
20th Oct 201712:07 pmRNSSecond Price Monitoring Extn
20th Oct 201712:02 pmRNSPrice Monitoring Extension
20th Oct 20177:00 amRNSBoard Changes
20th Oct 20177:00 amRNSPreliminary Results
9th Oct 20177:00 amRNS£24m Fundraising, CEO Appointment & Board Changes
29th Sep 201712:21 pmRNSRe: Property Transaction
28th Sep 20177:00 amRNSMajor New Contract with IKEA
22nd Sep 20177:00 amRNSFinancing Update, Property Disposal, Gatemore Loan
20th Sep 20174:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.